Glycosylation of low density lipoprotein in patients with Type I (insulin-dependent) diabetes: Correlations with other parameters of glycaemic control

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Diabetologia

• Publication date

  1986-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00870276PMID 3803742
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes and cardiovascular disease.

  1999cited by this paper
• Plasma Apolipoproteins AI, AII, B, CI, and E Are Glucosylated in Hyperglycemic Diabetic Subjects

  1985cited by this paper
• Non-enzymatic glycosylation and the chronic complications of diabetes: an overview

  1984cited by this paper
• Glucosylation of Low-Density Lipoproteins to an Extent Comparable to That Seen in Diabetes Slows Their Catabolism

  1984cited by this paper
• Nonenzymatic glucosylation of lysine residues in albumin.

  1984cited by this paper
• Non-enzymatic glycosylation of tissue protein in diabetes in the rat

  1983cited by this paper
• The Bedford Survey: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics

  1982cited by this paper
• Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from Type 1 (insulin-dependent) diabetic patients: Changes with metabolic control

  1982cited by this paper
• Nonenzymatic Glucosylation of Low-Density Lipoprotein Alters Its Biologic Activity

  1982cited by this paper
• Non‐enzymatic glycosylation of human serum lipoproteins Elevated ϵ‐lysine glycosylated low density lipoprotein in diabetic patients

  1981cited by this paper
• Nonenzymatic Glycosylation of Low Density Lipoproteins In Vitro: Effects on Cell-interactive Properties

  1981cited by this paper
• Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

  1980cited by this paper
• Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

  1979cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979cited by this paper
• Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance

  1979cited by this paper
• A Simplified Assay of Hemoglobin AIc in Diabetic Patients by Use of Isoelectric Focusing and Quantitative Microdensitometry

  1978cited by this paper
• Cholesterol determination in high-density lipoproteins separated by three different methods.

  1977cited by this paper
• An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines.

  1975cited by this paper
• Morbidity and Mortality in Diabetics In the Framingham Population: Sixteen Year Follow-up Study

  1974cited by this paper
• Education and Welfare

  1973cited by this paper
• The measurement of amino groups in proteins and peptides.

  1971cited by this paper
• A New and Rapid Method for the Determination of Glucose by Measurement of Rate of Oxygen Consumption

  1968cited by this paper
• Health, Education, and Welfare.

  1965cited by this paper
• THE AMERICAN AND HIS DIET.

  1964cited by this paper
• Studies on the metabolism of plasma proteins in the nephrotic syndrome. II. The lipoproteins.

  1958cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• STUDIES ON THE METABOLISM OF PLASMA PROTEINS IN THE NEPHROTIC SYNDROME. y-GLOBULIN AND IRON-BINDING GLOBULIN1

  year unknowncited by this paper

• Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate

  2024cites this paper
• Synergism of mechanisms underlying early-stage changes in retina function in male hyperglycemic db/db mice in the absence and presence of chemically-induced dyslipidemia

  2023cites this paper
• Changes in Impaired Fasting Glucose and Borderline High Low-Density Lipoprotein-Cholesterol Status Alter the Risk of Cardiovascular Disease: A 9-Year Prospective Cohort Study

  2022cites this paper
• Dyslipidemia in Type 1 Diabetes: A Masked Danger.

  2020cites this paper
• Investigating the relationship between myocardial infarction and the ratio of glycated albumin to glycated hemoglobin in patients admitted to cardiac ward

  2020cites this paper
• Syzygium cumini leaf extract inhibits LDL oxidation, but does not protect the liproprotein from glycation.

  2018cites this paper
• Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress

  2018influential citation
• Serum fructosamine, serum glycated albumin and serum glycated β-lipoprotein in type 2 diabetes mellitus patients with and without microvascular complications

  2016cites this paper
• Lipids and Diabetic Retinopathy

  2016cites this paper
• Chapter 1 Diabetes: a growing epidemic and the need for point-of-care testing

  2016cites this paper
• Relationships between iron, oxidative stress, glycated proteins and the development of atherosclerosis in Type 2 diabetes

  2015cites this paper
• Tools for Assessing Lipoprotein Metabolism in Diabetes Mellitus

  2014cites this paper
• Roles of Extravasated and Modified Plasma Lipoproteins in Diabetic Retinopathy

  2014cites this paper
• Effects of modified LDL and HDL on retinal pigment epithelial cells: a role in diabetic retinopathy?

  2013cites this paper
• Relationship of PON1 activity and hsCRP concentration with disease status in patients with type 2 diabetes mellitus with and without retinopathy

  2013cites this paper
• Mechanisms of modified LDL-induced pericyte loss and retinal injury in diabetic retinopathy

  2012cites this paper
• The Roles of Glycated Albumin as Intermediate Glycation Index and Pathogenic Protein

  2012cites this paper
• Lipoprotein Modification: A Hallmark In The Progression Of Diabetic Nephropathy

  2012cites this paper
• Oxidative and endoplasmic reticulum stresses mediate apoptosis induced by modified LDL in human retinal Müller cells.

  2012cites this paper
• Tyrosine nitration of prostacyclin synthase is associated with enhanced retinal cell apoptosis in diabetes.

  2011cites this paper
• Inhibiting low-density lipoprotein glycation ameliorates increased cholesteryl ester synthesis in macrophages and hypercholesterolemia and aortic lipid peroxidation in streptozotocin diabetic rats.

  2010cites this paper
• Syndrome métabolique et diabète chez l'Homme. Composition lipidique et oxydation des lipoprotéines de basse densité (LDL) plasmatiques en relation avec l'activation des plaquettes sanguines.

  2010cites this paper
• Inhibiting LDL glycation ameliorates increased cholesteryl ester synthesis in macrophages and hypercholesterolemia and aortic lipid peroxidation in streptozotocin diabetic rats

  2010cites this paper
• Impairment of mitochondrial respiratory chain activity in aortic endothelial cells induced by glycated low-density lipoprotein.

  2010cites this paper
• Apoptosis induction by oxidized glycated LDL in human retinal capillary pericytes is independent of activation of MAPK signaling pathways

  2009cites this paper
• Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro.

  2009cites this paper
• Intraretinal leakage and oxidation of LDL in diabetic retinopathy.

  2008cites this paper
• A Review of Glycated Albumin as an Intermediate Glycation Index for Controlling Diabetes

  2008cites this paper
• Oxidised, glycated LDL selectively influences tissue inhibitor of metalloproteinase-3 gene expression and protein production in human retinal capillary pericytes

  2007cites this paper
• Oxidatively Modified Low-Density Lipoproteins and Thrombosis

  2006cites this paper
• Glycation Accelerates Lipoprotein by Copper the Oxidation of Low Densi Ions

  2006cites this paper
• Effects of oxidized and glycated low-density lipoproteins on transcription and secretion of plasminogen activator inhibitor-1 in vascular endothelial cells.

  2006cites this paper
• Functional modulation of antioxidant enzymes in vascular endothelial cells by glycated LDL.

  2005cites this paper
• Diabetes and Atherosclerosis

  2005cites this paper
• Towards a New Glycation Index

  2005influential citation
• Glycation Does Not Alter LDL‐Induced Secretion of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor‐1 from Human Aortic Endothelial Cells

  2005cites this paper
• Effects of Modified Low‐Density Lipoproteins on Human Retinal Pericyte Survival

  2005cites this paper
• A lethal tetrad in diabetes: hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction.

  2005cites this paper
• Impact of in vivo glycation of LDL on platelet aggregation and monocyte chemotaxis in diabetic Psammomys obesus

  2004cites this paper
• Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells

  2004cites this paper
• In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type 1 diabetes.

  2004cites this paper
• Effet d'un hydroperoxyde lipidique et des LDL oxydées sur les enzymes impliquées dans la libération de l'acide arachidonique des phospholipides plaquettaires

  2004cites this paper
• Dyslipoproteinemia and Fibrinolysis

  2003cites this paper
• Diabetic LDL triggers apoptosis in vascular endothelial cells.

  2003cites this paper
• Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells.

  2003cites this paper
• Atherosclerosis, Hypertension and Diabetes

  2003cites this paper
• Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients

  2003cites this paper
• Impact of diabetes-associated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells.

  2002cites this paper
• Improved glucose control decreases the interaction of plasma low-density lipoproteins with arterial proteoglycans.

  2002cites this paper
• Activation of MAPK by modified low-density lipoproteins in vascular smooth muscle cells.

  2001cites this paper
• Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1.

  2001cites this paper
• [Autoantibodies against advanced glycation products in patients with type 1 diabetes mellitus].

  2001cites this paper
• Prostaglandins and lipid modification.

  2001cites this paper
• Composition of LDL as determinant of its susceptibility to in vitro oxidation in patients with well‐controlled type 2 diabetes

  2001cites this paper
• Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells.

  2000cites this paper
• [Lipoprotein glycation and glycoxidation: their importance in diabetes mellitus].

  2000cites this paper
• Impact of antioxidants and HDL on glycated LDL-induced generation of fibrinolytic regulators from vascular endothelial cells.

  2000cites this paper
• Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study.

  2000cites this paper
• The effects of glycation/glycoxidation on the liberation of 8-epi-PGF2alpha from low density lipoprotein during its in vitro oxidation.

  2000cites this paper
• Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre‐oxidative condition?

  1999cites this paper
• Measuring Glycated Proteins: Clinical and Methodological Aspects

  1999cites this paper
• Glycation of plasma low density lipoproteins increases interaction with arterial proteoglycans.

  1999cites this paper
• Detection of structural alterations in LDL isolated from type 2 diabetic patients: application of the fructosamine assay to evaluate the extent of LDL glycation.

  1999cites this paper
• Short-term variations of serum glycated apolipoprotein B.

  1998cites this paper
• Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells.

  1998cites this paper
• Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications

  1998cites this paper
• Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis.

  1997cites this paper
• [Non-enzymatic glycosylation of lipoproteins in the pathogenesis of atherosclerosis in diabetics].

  1997cites this paper
• [Non-enzymatic glycosylation in diabetes mellitus].

  1997cites this paper
• Lipoprotein glycation and its metabolic consequences.

  1997cites this paper
• Glycation, oxidation, and lipoxidation in the development of diabetic complications.

  1997cites this paper
• A monoclonal antibody-based enzyme immunoassay for the measurement of native and glycated apolipoprotein B-containing particles.

  1997cites this paper
• Immune Response to Glycated and Oxidized LDL in IDDM Patients With and Without Renal Disease

  1997cites this paper
• Increased glycation of plasma lipoproteins in diabetic cynomolgus monkeys.

  1996cites this paper
• Platelet aggregation in type 1 diabetes without microvascular disease during continuous subcutaneous insulin infusion.

  1996cites this paper
• Increased macrophage uptake of irreversibly glycated albumin modified-low density lipoproteins of normal and diabetic subjects is mediated by non-saturable mechanisms.

  1996cites this paper
• Modification of lipoproteins in diabetes.

  1996cites this paper
• Modified lipoproteins, cytokines and macrovascular disease in non-insulin-dependent diabetes mellitus.

  1996cites this paper
• Insights into the pathogenesis and prevention of coronary artery disease.

  1995cites this paper
• Enhancement of prostacyclin production in cultured bovine aortic endothelial cells by oxidized glycated low-density lipoprotein.

  1995cites this paper
• Glucose‐enriched medium enhances cell‐mediated low density lipoprotein peroxidation

  1995cites this paper
• Lipoprotein profile after combined kidneypancreas transplantation in insulindependent diabetes mellitus

  1995cites this paper
• Plasma Oxidizability in Subjects With Normal Glucose Tolerance, Impaired Glucose Tolerance, and NIDDM

  1995cites this paper
• Nonenzymic glycation of apolipoprotein B in patients with insulin- and noninsulin-dependent diabetes mellitus.

  1995cites this paper
• Metabolism of Oxidized Glycated Low-Density Lipoprotein in Cultured Bovine Aortic Endothelial Cells

  1995cites this paper
• Glycation accelerates the oxidation of low density lipoprotein by copper ions.

  1995cites this paper
• Release of superoxide radicals by mouse macrophages stimulated by oxidative modification of glycated low density lipoproteins.

  1995cites this paper
• Serum Glycated Lipoproteins in Type II Diabetic Patients with and without Complications

  1995cites this paper
• Irreversibly glycated albumin alters the physico-chemical characteristics of low density lipoproteins of normal and diabetic subjects.

  1995cites this paper
• Glycation of lipoproteins and accelerated atherosclerosis in non-insulin-dependent diabetes mellitus

  1995cites this paper
• Non-enzymatic glycation of lipoprotein(a) in vitro and in vivo.

  1995cites this paper
• Hypertension and diabetic vascular complications.

  1994cites this paper
• [Hyperlipidemia during diabetes mellitus. Recent developments].

  1994cites this paper
• The role of oxidation and glycation in the pathogenesis of diabetic atherosclerosis.

  1994cites this paper
• Determination of Glycated Apolipoprotein B in Serum by a Combination of Affinity Chromatography and Immunonephelometry

  1994cites this paper
• Glycation and oxidation: a role in the pathogenesis of atherosclerosis.

  1993cites this paper
• [Correlations of the levels of HbA1c with plasma apoproteins and plasma lipoproteins in type II diabetic patients].

  1993cites this paper
• Glycated LDL Concentrations in Non-Diabetic and Diabetic Subjects Measured with Monoclonal Antibodies Reactive with Glycated Apolipoprotein B Epitopes

  1993cites this paper
• Lipoprotein Glycation and Its Metabolic Consequences

  1992cites this paper
• Influence of Glycemic Control on Interaction of Very-Low- and Low-Density Lipoproteins Isolated From Type I Diabetic Patients With Human Monocyte-Derived Macrophages

  1992cites this paper